Funds Donated by The Blue Buffalo Foundation Will Help Map the Most Common Canine Cancer Genomes
"We are proud to support Animal Cancer Foundation in their important work helping to find ways to cure this terrible disease affecting pets." David Petrie, President, Blue Buffalo Foundation
Huntsman Cancer Institute and School of Medicine University of Utah
"We are very excited to receive this award to test elephant p53 (EP53) in growing cancer cells that come from pet dogs that naturally develop cancers... we will focus specifically on dog sarcomas that also occur in pediatric patients."
School of Veterinary Medicine, University of Pennsylvania
"We are absolutely delighted to receive this award from the Animal Cancer Foundation. This award supports our on-going work developing genetically re-directed T cells to provide complete and durable remission in dogs with B cell lymphoma."
Oregon State University-Ramsey Lab, and Shay Bracha DVM, MS, DACVIM (Oncology), OSU College of Veterinary Medicine
"The grant will enable us to leverage the power of genomics technologies and comparative oncology to develop predictive models of how a canine malignancy will respond to chemotherapeutic treatment, based on the tumor's molecular profile."
The Research Institute at Nationwide Children's Hospital and Assistant Professor, The Ohio State University College of Medicine
“Kids and animals often develop very similar types of cancer. When pediatricians, scientists, and veterinarians work together, research can improve treatments not only for children, but for their ‘best friends’ too.”
DVM, MS, DACVIM (Oncology), Director of Clinical Trials, Colorado State University Flint Animal Cancer Center
"The grant allows our team to investigate the effects of AF in tumor-bearing dogs to establish a biologically effective dose, which has near-term benefit in the treatment of dogs with lymphoma and is a translational model for human cancer."
DVM, PhD, Assistant Professor of Comparative and Radiation Oncology, Cummings School of Veterinary Medicine at Tufts University
“By bridging human & veterinary medicine at Tufts, we have created a unique opportunity to promote cancer research to benefit both pets and people. With ACF's help, we can advance our studies & demonstrate the value in this approach.”
DVM, MS, Dipl. ACVIM (Oncology Specialty) Dolores L. McCall Professor of Comparative Oncology, Purdue University
"Bladder cancer has not been a focus of human studies, but the ACF-supported work in dogs is now providing strong justification to consider this approach for human bladder cancer as well as other human cancers."
Wendy Lee with Dr. Nicola Mason, April 27, 2018
Recently, a new treatment for human B cell cancers called CAR - T (Chimeric Antigen Receptor T cell) therapy has made headlines around the world, because the new immunotherapuetic treatment ...
Barbara Cohen, March 9, 2018
My veterinary oncologist wrote a compounding pharmacy prescription for my pet. Why? In many circumstances, cancer therapeutics are not specifically manufactured for our pets. This is especially true, ...
Barbara Cohen, November 5, 2017
Animal Cancer Foundation is pleased to announce that its annual ACF Comparative Oncology Grant Award for 2017 has been presented to Joshua Schiffman, MD, Professor of Pediatrics at the University ...
Gerald S. Post, DVM, MEM, DACVIM (Oncology), ACF Founder & Barbara Cohen, Executive Director, May 1, 2017
Pet Parents who welcome new puppies and kittens into their families likely aren’t thinking that their precious new addition could someday be diagnosed with cancer. Most of ...
Sunday, May 13, 2018
You Shop. Amazon Gives. Amazon donates 0.5% of the price of your eligible AmazonSmile purchases to the charitable organization of your choice. Hint: Animal Cancer Foundation! Same Amazon. ...
Sunday, May 13, 2018
Enroll in IGIVE and every time you shop using the browser, a percentage of your purchase price will be donated to Animal Cancer Foundation. GIVE as you shop this Mother' ...